TLPH
TLPH
NASDAQ · Pharmaceuticals

Talphera Inc

$1.35
-0.01 (-0.74%)
As of Aug 8, 2:23 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,835.6% upside
Low Target $16.33
Average Target $26.13
High Target $37.99
Current Price $1.35
Current
$1.35
Target
$26.13
$16.33 $26.13 avg $37.99
Scenario Analysis
Bear Case
$16.33
1,109.6%
Low target
Base Case
$26.13
+1,835.6%
Avg target
Bull Case
$37.99
+2,714.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$1.57
-14.0% from high
52-Week Low
$0.39
+249.6% from low
Target vs 52W High
$26.13
+1,564.3% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.07
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%